Hikma Pharmaceuticals Plc Stock Price, News & Analysis (OTCMKTS:HKMPF)

$12.40 0.00 (0.00 %)
(As of 11/17/2017 04:00 PM ET)
Previous Close$12.40
Today's Range$12.40 - $12.40
52-Week Range$12.40 - $27.50
VolumeN/A
Average Volume28 shs
Market Capitalization$2.98 billion
P/E RatioN/A
Dividend Yield2.58%
BetaN/A

About Hikma Pharmaceuticals Plc (OTCMKTS:HKMPF)

Hikma Pharmaceuticals Plc logoHikma Pharmaceuticals PLC develops, manufactures, and markets a range of generic, branded, and in-licensed pharmaceutical products in solid, semi-solid, liquid, and injectable final dosage forms worldwide. It operates through three segments: Branded, Injectables, and Generic. The Branded segment offers 377 products in 1,125 dosage forms and strengths in the anti-infective, cardiovascular, diabetes, central nervous system (CNS), gastro-intestinal, oncology, respiratory, and miscellaneous therapeutic areas. This segment’s principal products include Amoclan, Blopress, Omnicef, Prograf, and Suprax. The Injectables segment markets 201 products in 571 dosage strengths and forms for anti-infective, cardiovascular, diabetes, controlled substances, gastro-intestinal, oncology, CNS, respiratory, and miscellaneous therapeutic areas. This segment also offers sterile liquid, powder, lyophilized, and cytotoxic products. This segment’s principal products include fentanyl, glycopyrrolate, neostigmine, nicardipine, and thiotepa. The Generics segment provides 109 products in 375 dosage strengths and forms for therapeutic areas, including anti-infective, controlled substances, oncology, and miscellaneous therapeutic areas. This segment’s principal products include amoxicillin, buprenorphine, butalbital, acetaminophen and caffeine, colchicine, and fluticasone. This segment markets its products to chain stores, wholesalers, distributors, health systems, and governmental agencies in the form of tablets, capsules, solutions, and suspensions. In addition, the company manufactures plastic specialized medicinal sterile containers and APIs; and conducts bio-equivalency studies. Hikma Pharmaceuticals PLC was founded in 1978 and is based in London, the United Kingdom.


Industry, Sector and Symbol:
  • Industry: N/A
  • Sub-Industry: N/A
  • Sector: Medical
  • Symbol: OTCMKTS:HKMPF
  • Previous Symbol: OTC:HKMPF
  • CUSIP: N/A
  • Web: www.hikma.com
Price-To-Earnings:
  • Forward P/E Ratio: 13.33
  • P/E Growth: 1.76
Sales & Book Value:
  • Annual Sales: $1.95 billion
  • Price / Sales: 1.53
  • Book Value: N/A
  • Price / Book: N/A
Dividend:
  • Annual Dividend: $0.22
  • Dividend Yield: 2.6%
Misc:
  • Employees: 8,500
  • Outstanding Shares: 240,660,000
 

Frequently Asked Questions for Hikma Pharmaceuticals Plc (OTCMKTS:HKMPF)

What is Hikma Pharmaceuticals Plc's stock symbol?

Hikma Pharmaceuticals Plc trades on the OTCMKTS under the ticker symbol "HKMPF."

Who are some of Hikma Pharmaceuticals Plc's key competitors?

How do I buy Hikma Pharmaceuticals Plc stock?

Shares of Hikma Pharmaceuticals Plc can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Hikma Pharmaceuticals Plc's stock price today?

One share of Hikma Pharmaceuticals Plc stock can currently be purchased for approximately $12.40.

How big of a company is Hikma Pharmaceuticals Plc?

Hikma Pharmaceuticals Plc has a market capitalization of $2.98 billion and generates $1.95 billion in revenue each year. Hikma Pharmaceuticals Plc employs 8,500 workers across the globe.

How can I contact Hikma Pharmaceuticals Plc?

Hikma Pharmaceuticals Plc's mailing address is 1 NEW BURLINGTON PLACE, LONDON X0, W1S 2HR. The company can be reached via phone at 44-20-7399-2760 or via email at [email protected]


MarketBeat Community Rating for Hikma Pharmaceuticals Plc (OTCMKTS HKMPF)

Community Ranking:  1.8 out of 5 (star)
Outperform Votes:  26 (Vote Outperform)
Underperform Votes:  45 (Vote Underperform)
Total Votes:  71
MarketBeat's community ratings are surveys of what our community members think about Hikma Pharmaceuticals Plc and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Analysts' Consensus Rating for Hikma Pharmaceuticals Plc (OTCMKTS:HKMPF)

  (How are Consensus Ratings Calculated?)
Ratings Breakdown: 0 Sell Ratings, 4 Hold Ratings, 0 Buy Ratings, 0 Strong Buy Ratings
Consensus Rating:Hold (Score: 2.00)
Analysts' Consensus Price Target: N/A

Consensus Price Target History for Hikma Pharmaceuticals Plc (OTCMKTS:HKMPF)

Price Target History for Hikma Pharmaceuticals Plc (OTCMKTS:HKMPF)

Analysts' Ratings History for Hikma Pharmaceuticals Plc (OTCMKTS:HKMPF)

Show:
DateFirmActionRatingPrice TargetDetails
8/22/2017The Goldman Sachs Group, Inc.DowngradeBuy -> NeutralView Rating Details
8/21/2017Jefferies Group LLCUpgradeUnderperform -> HoldView Rating Details
8/8/2017Morgan StanleyReiterated RatingEqual WeightView Rating Details
5/19/2017Numis Securities LtdReiterated RatingBuy -> AddView Rating Details
(Data available from 11/18/2015 forward)

Earnings

Earnings History for Hikma Pharmaceuticals Plc (OTCMKTS:HKMPF)


No earnings announcements for this company have been tracked by MarketBeat.com

Estimates

Earnings Estimates for Hikma Pharmaceuticals Plc (OTCMKTS:HKMPF)
Current Year EPS Consensus Estimate: $0.93 EPS
Next Year EPS Consensus Estimate: $1 EPS

Dividends

Dividend History for Hikma Pharmaceuticals Plc (OTCMKTS:HKMPF)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Hikma Pharmaceuticals Plc (OTCMKTS HKMPF)
No insider trades for this company have been tracked by MarketBeat.com

Headlines

Headline Trends for Hikma Pharmaceuticals Plc (OTCMKTS:HKMPF)

Latest Headlines for Hikma Pharmaceuticals Plc (OTCMKTS HKMPF)

Source:
No headlines for this company have been tracked by MarketBeat.com

Social Media

Financials

Financials are not available for this stock.

Chart

Hikma Pharmaceuticals Plc (OTCMKTS HKMPF) Chart for Saturday, November, 18, 2017
Loading chart…

This page was last updated on 11/18/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.